highperformr logo

Alvotech's Overview

Total employees895
HeadquartersReykjavik
Founded2013

Alvotech is a global biopharmaceutical company singularly focused on the development and manufacture of biosimilar medicines for patients worldwide. Founded on the principle of improving access to high-quality, affordable biologics, Alvotech leverages its fully integrated platform, from cell line development to commercial manufacturing, to bring critical treatments to market. The company's pipeline spans various therapeutic areas, aiming to address unmet medical needs and enhance healthcare sustainability through its innovative biosimilar solutions.

Where is Alvotech's Headquarters?

HQ Function

Serves as Alvotech's global corporate headquarters and houses a state-of-the-art, vertically integrated research, development, and cGMP manufacturing facility for biosimilars.

Notable Features:

Advanced, fully integrated biopharmaceutical facility with capabilities for cell line development, process development, analytical testing, and large-scale commercial manufacturing. Designed for flexibility and efficiency in biosimilar production.

Work Culture:

A dynamic and science-driven environment fostering innovation, collaboration, and a commitment to quality. Employees are dedicated to the mission of improving global access to affordable medicines.

HQ Significance:

The Reykjavik facility is the cornerstone of Alvotech's end-to-end biosimilar development and manufacturing strategy, enabling control over the entire value chain and ensuring high-quality production standards for global markets.

Values Reflected in HQ: The facility reflects Alvotech's commitment to scientific excellence, innovation, quality, and the efficient production of affordable biosimilar medicines for patients globally.

Location:

Alvotech operates a global network supporting end-to-end biosimilar development and commercialization. This includes R&D and manufacturing in Iceland, commercial operations in Switzerland, manufacturing in Germany, and a strategic presence in the USA. The company collaborates with a network of global and regional partners for clinical trials, regulatory submissions, and commercial distribution of its biosimilars in markets across North America, Europe, Asia-Pacific, Latin America, and the Middle East.

Street Address:

Sæmundargata 15-19

City:

Reykjavik

State/Province:

Capital Region

Country:

Iceland

Alvotech's Global Presence

Zurich, Switzerland

Address: Alvotech Swiss AG, Tessinerplatz 7, 8002 Zürich, Switzerland

To drive Alvotech's commercial strategy and market access for its biosimilar portfolio across Europe and other international markets (excluding the US).

Jülich, Germany

Address: Alvotech Germany GmbH, Karl-Heinz-Beckurts-Straße 13, 52428 Jülich, Germany

To provide specialized manufacturing capabilities and capacity for Alvotech's growing pipeline of biosimilar products, supporting both clinical and commercial supply needs.

Research Triangle Park, North Carolina, USA

Address: Alvotech USA Inc., (Specific address may vary, RTP area)

To establish and expand Alvotech's presence in the U.S., facilitating market entry and commercialization of its biosimilar products.

Buying Intent Signals for Alvotech

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Alvotech

As of April 2025, Alvotech' leadership includes:

Robert Wessman - Chairman and Chief Executive Officer
Joel Morales - Chief Financial Officer
Ming Li - Chief Strategy Officer
Sarah Kennedy - Chief People Officer
Joseph McClellan - Chief Scientific Officer
Christina Siniscalchi - Chief Commercial Officer, US
Anil Okay - Chief Commercial Officer, Rest of World
Sandra Casaca - Chief Operations Officer (interim)
Erlendur Lárusson - Chief Quality Officer
Vaishali Sharma - General Counsel

Investors of Alvotech

Alvotech has been backed by several prominent investors over the years, including:

Aztiq Pharma (Founder and significant shareholder group)
Publicly traded on NASDAQ (Ticker: ALVO) and the Nasdaq First North Growth Market in Iceland (Ticker: ALVO)
Various institutional and retail investors

Executive New Hires/Exits in the Last 12 Months

Hire4
Exits3

Alvotech has experienced several key executive transitions in the past year (June 2023 - June 2024), notably the appointment of founder Robert Wessman as CEO, a new CFO, a new General Counsel, and a new CCO for the US market, signaling strategic shifts and a focus on commercial growth.

Departures

Mark Levick, Mark Levick stepped down as CEO.
Ken Cheung, Ken Cheung departed as CFO.
Arni Hardarson, Arni Hardarson departed as Chief Operating Officer.

New Appointments:

Robert Wessman, Robert Wessman, Founder and Chairman, appointed as CEO.
Joel Morales, Joel Morales appointed as new Chief Financial Officer.
Vaishali Sharma, Vaishali Sharma appointed as General Counsel.
Christina Siniscalchi, Christina Siniscalchi appointed as Chief Commercial Officer, US.

Technology (Tech Stack) used by Alvotech

Discover the tools Alvotech uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Alvotech Email Formats and Examples

Alvotech commonly utilizes email formats such as [first_name].[last_name]@alvotech.com or [first_initial][last_name]@alvotech.com. For executives and general inquiries, specific departmental or role-based emails might also be in use.

firstname.lastname@alvotech.com

Format

jane.doe@alvotech.com

Example

90%

Success rate

News and media

Alvotech Press ReleaseJune 3, 2024

Alvotech and Teva Announce U.S. FDA Approval of SIMLANDI® (adalimumab-ryvk) injection, the First High-Concentration, Citrate-Free Biosimilar to Humira®

Alvotech and Teva Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved SIMLANDI® (adalimumab-ryvk) injection, a high-concentration, citrate-free biosimilar to Humira®. This marks a significant milestone for Alvotech in providing a key biosimilar to the U.S. market....more

Alvotech Press ReleaseMay 23, 2024

Alvotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Alvotech reported its financial results for the first quarter ended March 31, 2024, and provided an update on recent corporate achievements, including progress in its biosimilar pipeline and commercial partnerships....more

Alvotech Press ReleaseMay 7, 2024

Alvotech Announces CEO Transition

Alvotech announced that its Board of Directors has appointed Robert Wessman, Alvotech’s Founder and Chairman, as Chief Executive Officer, effective May 7, 2024. Mr. Wessman succeeded Mark Levick, who stepped down as CEO....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Alvotech, are just a search away.